Acellular pertussis vaccine given by accelerated schedule: Response of preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 89, Issue 1, 2004, Pages

  Slack, M H ^a   Schapira, D ^b   Thwaites, R J ^a   Schapira, C ^b   Bamber, J ^c   Burrage, M ^d   Southern, J ^d   Andrews, N ^d   Miller, E ^d  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^c PRINCESS ANNE HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN G; PERTACTIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; STEROID;

ANTIBODY RESPONSE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIPHTHERIA; DRUG DOSE REGIMEN; FEMALE; GESTATIONAL AGE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; STEROID THERAPY; TETANUS; TREATMENT OUTCOME; UNITED KINGDOM; VACCINATION;

EID: 1642492964     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.89.1.f57     Document Type: Article

References (10)

1. Olin P, Rasmussen F, Gustafsson L, et al. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole cell pertussis vaccine. Lancet 1997;350:1569-77.
2. Department of Health. Immunisation against infectious diseases, 1996. London: HMSO, 1996.
3. Ramsay ME, Miller E, Ashworth LAE, et al. Adverse events and antibody response to accelerated immunisation in term and preterm infants. Arch Dis Child 1995;72:230-2.
4. D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely preterm infants to tetanus, Haemophilus influenzae and polio immunizations. Pediatrics 1995;96:18-22.
5. Bernbaum JC, Daft A, Anolik R, et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr 1985;107:184-8.
6. Conway S, James J, Balfour A, et al. Immunisation of the preterm baby. J Infect 1993;27:143-50.
7. Robinson MJ, Campbell F, Powell P, et al. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999;80:F69-71.
8. Slack MH, Schapira D, Thwaites RJ, et al. Immune response of preterm infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis 2001;184:1617-20.
9. Schloesser RL, Fischer D, Otto W, et al. Safety and immunogenicity of an acellular pertussis vaccine in preterm infants. Pediatrics 1999;103:e60.
10. Faldella G, Alessandroni R, Magini GM, et al. The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine 1998;16:1646-9.